On the basis of the evidence that dehydroeffusol prevents human amyloid-β-induced memory deficit and neurodegeneration in mice, here we tested the effect of a Juncus effusus extract powder enriched with dehydroeffusol on the cognitive and dexterous performance of elderly people. A randomized, double-blind, placebo-controlled, parallel-group study was conducted in 41 participants (averaged age: 69 years) randomly divided into test and placebo groups who received a test tablet and a placebo tablet, respectively, once a day for 24 weeks. Changes in cognitive function were assessed using the Five-Cog test 24 weeks after the start of intake. The task scores of the test group were significantly higher in the clue recall and clock-drawing tasks than in the placebo group, suggesting that intake of J. effusus extract powder may improve the cognitive function of elderly people. Moreover, the task score of the test group was significantly higher for the assembly task in the dexterity test than the placebo group, suggesting that intake of J. effusus extract powder may improve the dexterous movement of elderly people. No adverse events were clinically observed during the study. The present study first suggests that intake of J. effusus extract powder enriched with dehydroeffusol is of benefit to the cognitive and dexterous performance of elderly people.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nut.2025.112712DOI Listing

Publication Analysis

Top Keywords

effusus extract
20
extract powder
20
elderly people
20
powder enriched
12
enriched dehydroeffusol
12
cognitive dexterous
12
dexterous performance
12
performance elderly
12
intake effusus
12
juncus effusus
8

Similar Publications

On the basis of the evidence that dehydroeffusol prevents human amyloid-β-induced memory deficit and neurodegeneration in mice, here we tested the effect of a Juncus effusus extract powder enriched with dehydroeffusol on the cognitive and dexterous performance of elderly people. A randomized, double-blind, placebo-controlled, parallel-group study was conducted in 41 participants (averaged age: 69 years) randomly divided into test and placebo groups who received a test tablet and a placebo tablet, respectively, once a day for 24 weeks. Changes in cognitive function were assessed using the Five-Cog test 24 weeks after the start of intake.

View Article and Find Full Text PDF

Effusol ameliorates ischemic stroke by targeting NLRP3 protein to regulate NLRP3 inflammasome-mediated pyroptosis.

Phytomedicine

January 2025

Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Key Laboratory of Data Analytics and Optimization for Smart Industry, Ministry of Education, Northeastern University, Shenyang, PR China. Electronic address:

Background: The significance of pyroptosis as an inflammatory mode of death in ischemic stroke (IS) has attracted much attention in recent years. Effusol is a dihydrophenanthrene component extracted from Juncus effusus L..

View Article and Find Full Text PDF
Article Synopsis
  • The study explores Juncus plant fibers as a sustainable source for creating cellulose nanocrystals (CNs) to strengthen polymers.
  • CNs were extracted using alkaline and bleaching treatments, followed by sulfuric acid hydrolysis, resulting in four types with varying properties, which positively influenced k-carrageenan (CA) biocomposite films.
  • Results showed significant improvements in thermal, transparency, and mechanical properties, particularly with an 8% CN loading, emphasizing the compatibility of CNs with the CA matrix and the benefits of hydrolysis duration on CN characteristics.
View Article and Find Full Text PDF

This study investigated the hepatoprotective effects of Juncus effusus (J. effusus) and Carbonized J. effusus against liver injury caused by D-galactosamine (D-GalN) in mice.

View Article and Find Full Text PDF

Anti-Inflammatory and Protective Effects of L. Water Extract on Oral Keratinocytes.

Biomed Res Int

January 2022

Department of Periodontology and Endodontology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Tokushima, Japan.

Periodontitis is a chronic inflammatory disease caused by periodontopathogenic bacteria that form biofilms in periodontal pockets. The gingival epithelium acts as the first physical barrier in fighting attacks by periodontopathogenic pathogens, such as the primary etiological agent , and various exogenous chemicals, as well as regulates the local innate immune responses. Therefore, the development of novel oral care products to inhibit inflammatory reactions caused by bacterial infection and protect the gingival epithelium is necessary.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!